Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which dressing heals leg ulcers faster? new study compares top options

NCT ID NCT05892341

Symptom relief Sponsor: ConvaTec Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two special wound dressings—AQUACEL® Ag+ Extra™ and Cutimed® Sorbact®—in 203 adults with venous leg ulcers. The goal was to see which one helps wounds heal better over 12 weeks. Participants had ulcers for at least 2 months and received compression therapy. The study measured complete wound closure and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

203 people

The number who actually took part.

Started

Dec 2022

Finished

Feb 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Venous insufficiency as defined by CEAP Classification of C6 * One wound amendable to treatment with either AQUACEL® Ag+ Extra™ or Cutimed® Sorbact® * Wounds that have been present for at least 2 months * Reliable and available for follow-up * 18 years or older * Able and willing to provide informed consent * Able to tolerate compression therapy for Venus Leg Ulcer * Must be able to be compliant with compression therapy Exclusion Criteria: * Known sensitivities or allergies to components of the AQUACEL® Ag+ Extra™ or Cutimed® Sorbact® * Continued use of petroleum gel/ creams/ oil-based products * Active treatment for cancer or completed within the last 3 months * Documented severe malnutrition * Malignant wounds * Systemic infection actively treated with antibiotics

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diabetic Foot ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot Venous leg ulcer

Contacts and locations

Locations

  • Convatec Colombia Clinic

    Barranquilla, Colombia

  • Convatec Colombia Clinic

    Bogotá, Colombia

  • Convatec Colombia Clinic

    Bucaramanga, Colombia

  • Convatec Colombia Clinic

    Cali, Colombia

  • Convatec Colombia Clinic

    Cartagena, Colombia

  • Convatec Colombia Clinic

    Medellín, Colombia

  • Germany

    Augsburg, Germany

  • Germany

    Berlin, Germany

  • Germany

    Bochum, Germany

  • Germany

    Düsseldorf, Germany

  • Germany

    Holzkirchen, Germany

  • Germany

    Ingolstadt, Germany

  • Germany

    Nuremberg, Germany

  • Germany

    Ratzeburg, Germany

  • Germany

    Rosenheim, Germany

  • Germany Clinic I

    München, Germany

  • Germany Clinic II

    München, Germany

  • VCTC UK

    Derby, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.